567 related articles for article (PubMed ID: 28332005)
1. Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.
Stepanović-Petrović R; Micov A; Tomić M; Pecikoza U
Psychopharmacology (Berl); 2017 Jun; 234(11):1781-1794. PubMed ID: 28332005
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam synergises with common analgesics in producing antinociception in a mouse model of painful diabetic neuropathy.
Micov A; Tomić M; Pecikoza U; Ugrešić N; Stepanović-Petrović R
Pharmacol Res; 2015 Jul; 97():131-42. PubMed ID: 25958352
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis.
Tanenberg RJ; Clemow DB; Giaconia JM; Risser RC
Pain Pract; 2014 Sep; 14(7):640-8. PubMed ID: 24152185
[TBL] [Abstract][Full Text] [Related]
4. Effect of levetiracetam versus gabapentin on peripheral neuropathy and sciatic degeneration in streptozotocin-diabetic mice: Influence on spinal microglia and astrocytes.
Reda HM; Zaitone SA; Moustafa YM
Eur J Pharmacol; 2016 Jan; 771():162-72. PubMed ID: 26712375
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the antinociceptive interactions in two-drug combinations of gabapentin, oxcarbazepine and amitriptyline in streptozotocin-induced diabetic mice.
Tomić MA; Vucković SM; Stepanović-Petrović RM; Micov AM; Ugresić ND; Prostran MS; Bosković B
Eur J Pharmacol; 2010 Feb; 628(1-3):75-82. PubMed ID: 19917280
[TBL] [Abstract][Full Text] [Related]
6. Interactions of pregabalin with gabapentin, levetiracetam, tiagabine and vigabatrin in the mouse maximal electroshock-induced seizure model: a type II isobolographic analysis.
Luszczki JJ; Filip D; Florek-Luszczki M
Epilepsy Res; 2012 Feb; 98(2-3):148-56. PubMed ID: 21944895
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of morphine, pregabalin, gabapentin, and duloxetine on mechanical allodynia is different from that on neuroma pain in the rat neuropathic pain model.
Miyazaki R; Yamamoto T
Anesth Analg; 2012 Jul; 115(1):182-8. PubMed ID: 22415534
[TBL] [Abstract][Full Text] [Related]
8. Advances in the management of diabetic neuropathy.
Várkonyi T; Körei A; Putz Z; Martos T; Keresztes K; Lengyel C; Nyiraty S; Stirban A; Jermendy G; Kempler P
Minerva Med; 2017 Oct; 108(5):419-437. PubMed ID: 28541026
[TBL] [Abstract][Full Text] [Related]
9. Ultra-Low Doses of Naltrexone Enhance the Antiallodynic Effect of Pregabalin or Gabapentin in Neuropathic Rats.
Pineda-Farias JB; Caram-Salas NL; Salinas-Abarca AB; Ocampo J; Granados-Soto V
Drug Dev Res; 2017 Dec; 78(8):371-380. PubMed ID: 28868795
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
[TBL] [Abstract][Full Text] [Related]
11. A cost-utility comparison of four first-line medications in painful diabetic neuropathy.
O'Connor AB; Noyes K; Holloway RG
Pharmacoeconomics; 2008; 26(12):1045-64. PubMed ID: 19014205
[TBL] [Abstract][Full Text] [Related]
12. Drug combinations in diabetic neuropathic pain: an experimental validation.
Tripathi CD; Mehta AK; Yadav AM
J Basic Clin Physiol Pharmacol; 2016 Nov; 27(6):617-624. PubMed ID: 27331307
[TBL] [Abstract][Full Text] [Related]
13. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients.
Ruessmann HJ;
J Diabetes Complications; 2009; 23(3):174-7. PubMed ID: 18403218
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK
Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive interaction of gabapentin with minocycline in murine diabetic neuropathy.
Miranda HF; Sierralta F; Jorquera V; Poblete P; Prieto JC; Noriega V
Inflammopharmacology; 2017 Feb; 25(1):91-97. PubMed ID: 28155118
[TBL] [Abstract][Full Text] [Related]
16. Clinical Trial Assessing the Efficacy of Gabapentin Plus B Complex (B1/B12) versus Pregabalin for Treating Painful Diabetic Neuropathy.
Mimenza Alvarado A; Aguilar Navarro S
J Diabetes Res; 2016; 2016():4078695. PubMed ID: 26885528
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis.
Dudra-Jastrzebska M; Andres-Mach MM; Sielski M; Ratnaraj N; Patsalos PN; Czuczwar SJ; Luszczki JJ
Eur J Pharmacol; 2009 Mar; 605(1-3):87-94. PubMed ID: 19168049
[TBL] [Abstract][Full Text] [Related]
18. Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine.
Bellows BK; Nelson RE; Oderda GM; LaFleur J
Pain; 2016 Jan; 157(1):203-213. PubMed ID: 26397932
[TBL] [Abstract][Full Text] [Related]
19. Pregabalin: new drug. Very similar to gabapentin.
Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
[TBL] [Abstract][Full Text] [Related]
20. Diabetic neuropathy: new strategies for treatment.
Várkonyi T; Kempler P
Diabetes Obes Metab; 2008 Feb; 10(2):99-108. PubMed ID: 17593238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]